Get informed when a big investor buys or sells
+ Follow10.22
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for 1295.TWO is 10.22. That is below the Healthcare sector average of 21.65. Investors often review this figure alongside Synbio Tech's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, 1295.TWO currently prints 10.22 for P/E ratio, while the sector average sits near 21.65. That is roughly 52.8% below the sector mean. Large gaps often invite a closer look at Synbio Tech's growth, margins, and balance sheet.
A P/E ratio of 10.22 for Synbio Tech is not 'good' or 'bad' on its own. Compare it with the peer average (21.65) and with 1295.TWO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting 1295.TWO's P/E ratio (10.22), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Synbio Tech's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.